Conformis IP Buys Time for New Products
The company benefitted from $41 million in one-time royalty and settlement payments in 2Q21 but its product revenue remains down vs. 2019. Aug 11, 2021
OrthoPediatrics Organic Growth Driven by Market Share Gains
The company's revenue grew double-digits in 2Q21 on the strength of share gains instead of recapturing backlogged procedures. Aug 11, 2021
Anika Therapeutics Remains On Course In Transition Year
The company benefitted from improving COVID conditions in 2Q21 and remains on course to achieve both short and long-term strategic goals. Aug 10, 2021
Orthofix Benefits from New Products to Offset COVID Impact
In 2Q21, the company grew modestly compared to the same period in 2019 due to newer products like the M-6 disc and FITBONE. Aug 09, 2021
Vericel on Track for Robust Second Half in 2021
The company outperformed expectations so far for 2021 and remains on track to realize growth in the 30% range for the full year. Aug 09, 2021
SI-BONE Takes Cautious View for 2021 Despite Momentum
Despite continued momentum in its underlying growth trajectory for 2Q21, the company is taking a cautious approach to the balance of the year. Aug 06, 2021
ATEC Drives Adoption of its Surgical Approach Thesis
In 2Q21 the company more than doubled its revenue from the second quarter of 2019, as adoption of its surgical approaches spread. Aug 05, 2021
SeaSpine Makes Ambitious Investment for 2021 Growth
The company continued its momentum in 2Q21 and made hefty investments to hit a targeted growth range of +30% to +33% for the full year. Aug 05, 2021
Globus Medical Enters Virtuous Cycles Through Robotics
The company set a new revenue record in 2Q21 thanks in large part to the synergistic impact of its ExcelsiusGPS robotic system. Aug 05, 2021
Zimmer Biomet Looks to Technology to Untrack Knee Franchise
In 2Q21 the company made impressive gains in sports medicine and extremities but has yet to find a path to above-market growth in knees. Aug 04, 2021
